Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home | Companies

Cipla Ltd.

Cipla Ltd.
Mumbai Central
Fax: 912-22-3095521

No. employees: 16,000
Turnover: 1,581.37 (US$m)
Financial year end: March

Company Overview

Cipla Ltd. (Cipla) is a pharmaceutical company. It offers various drugs and healthcare products. The company manufactures and commercializes various over-the-counter (OTC) products; prescription products; pesticides; flavors and fragrances; bulk drugs and animal products; agrochemicals; and technology. It offers these products in the form of tablets, capsules, injection, suspension, syrup and dispersible tablet. Cipla manages 34 manufacturing facilities that manufacture products in over 65 therapeutic categories. These facilities obtained certifications from major international regulatory agencies that include the US FDA; WHO; MHRA; TGA; SUKL; APVMA; MCC; PIC; Danish Medical Agency; INVIMA; NDA ; ANVISA ; and Department of Health among others. The company also entered various strategic partnerships with large generic pharmaceutical companies for product development and supply in over 170 countries. It operates through a single business segment, namely, pharmaceutical business. Cipla is headquartered in Mumbai, Maharashtra, India. The company continues to establish strategic marketing alliances and partnerships with research organizations and non-profit institutions for the development of novel formulations for infants and children. This intent is visible from Cipla's collaborations with Drugs for Neglected Diseases and Medical Research Council Clinical Trials Unit for the development of drug formulations for HIV-infected children and a new sprinkle of lopinavir-ritonavir.

Top Competitors